stockrow
Friday 6 November 2026
Export DNLI’s income statement to Excel — free account
Denali Therapeutics Inc.
DNLI Healthcare Biotechnology
Denali Therapeutics Inc.’s revenue for fiscal 2023 (year ended December 2023) was $330.5 million, up 204.7% from fiscal 2022.
- Revenue
- −94.0%
- EPS
- +150.3%
- Free cash flow
- −11.8%
- Total debt
- −1.89%
Quarter to September 2026, against a year earlier
20.12
0.40
+2.03%
Follow DNLI
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(45.69%) | (49.59%) | (54.93%) | (33.94%) | |
| (40.69%) | (40.04%) | (44.01%) | (27.20%) | ||
ROIC |
(229.23%) | 0.00% | (260.54%) | (80.00%) | |
Return on Tangible Assets |
(59.97%) | (52.68%) | (71.65%) | (57.76%) | |
Average Days of Receivables |
— | — | 4.79 | 304.29 | |
Free Cash Flow per Share |
(2.44) | (2.25) | (2.34) | (2.39) | |
Free Cash Flow |
(422.10) | (419.23) | (437.46) | (449.99) | |
Capital Expenditures |
(9.50) | (6.89) | (3.42) | (5.80) | |
| Other line items | |||||
Cash ROIC |
(22.37%) | (21.84%) | (28.20%) | (31.08%) | |
Accounts Receivable Turnover |
— | — | 152.28 | 1.90 | |
Accounts Payable Turnover |
0.00 | 0.00 | 1.13 | 0.38 | |
Inventory Turnover |
— | — | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 335.71 | 1,295.80 | |
Days of Inventory on Hand |
— | — | 117.69 | 2,485.20 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 134.02% | 1,787.59% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 48.41% | 647.88% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 31.80% | 409.78% | |
Operating CF/Net income |
0.81 | 0.81 | 0.85 | 1.41 | |
Depreciation/Fixed assets |
0.02 | 0.08 | 0.12 | 0.16 | |
Capex/Depreciation |
(10.22) | (1.69) | (0.58) | (0.77) | |
Revenue per Share |
0.00 | 0.00 | 1.60 | 0.12 | |
Operating CF per Share |
(2.39) | (2.21) | (2.32) | (2.36) | |
Capex per Share |
(0.05) | (0.04) | (0.02) | (0.03) | |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.26 |
Columns are period end dates · fundamentals updated 5 Nov 2026